Delivery Order SPE2D020D0014-SPE2D325F6844

Award Date 2/24/25
Potential Completion Date 2/27/25
Potential Value $59K
Federal Agency
Medical Supply Chain
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
New York, NY 10001, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $5,640.00 firm fixed-price delivery order awarded by the Defense Logistics Agency Troop Support Medical to Pfizer Inc., a global pharmaceutical corporation. The contract is for the delivery of 4,567,312,684 units of 4 mg/10 mL vials of the opioid overdose reversal drug Naloxone. The contract has a period of performance ending on February 24, 2025. This award is not associated with a set-aside program. Pfizer is the prime contractor and no subcontractors are mentioned. The Defense...
This is a federal delivery order contract awarded by the Medical Supply Chain, a component of the Defense Logistics Agency Troop Support, to Pfizer Inc. The contract is for the supply of 4 mg/10 ml vials of the opioid overdose reversal drug Naloxone, with a ceiling value of $2,820. The contract is a firm-fixed price arrangement with a period of performance extending through February 27, 2025. This contract is not designated as a small business set-aside. Pfizer is a large, for-profit...
This is a federal delivery order contract awarded by the Defense Logistics Agency Troop Support Medical to Pfizer Inc., a large pharmaceutical manufacturer, for the supply of Naloxone 4 mg/10 ml vials. The contract has a ceiling value of $2,820.00 and is a firm fixed price, delivery order contract type with a performance period ending on February 26, 2025. The contract does not utilize a small business set-aside designation. Pfizer is the prime contractor for this award, which is part of the...
This is a firm-fixed price delivery order awarded by the Defense Logistics Agency Troop Support Medical to Pfizer Inc. for the supply of Naloxone 4 mg/10 ml vials. The contract has a ceiling value of $11,280.00 and a completion date of September 24, 2024. This delivery order was awarded without the use of any set-aside designations. Pfizer is a large pharmaceutical corporation that serves as a prime contractor to various federal agencies, providing a wide range of pharmaceutical products,...
This is a $4,993.14 Firm Fixed Price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 4,565,056,293 units of Naloxone HCL 4 mg Nasal Spray, a critical medication used to treat opioid overdoses. The contract has an ultimate completion date of July 3, 2024 and was awarded on July 2, 2022. This delivery order is part of a larger Indefinite...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,210.86, is for the procurement of 4566845391 - NALOXONE 0.4 MG/ML VIALML. The contract has a completion date of January 7, 2025 and is a Firm Fixed Price contract. This order is part of a larger Indefinite Delivery Contract (IDC) the vendor holds with the DLA...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The $1,622.99 contract is for the supply of NALOXONE 0.4 MG/ML, a medication used to reverse opioid overdoses. This delivery order is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00, which serves as the primary vehicle for Amerisourcebergen...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 4,567,096 units of Naloxone 2 mg/2 ml syringes, a critical medication used to treat opioid overdoses. The contract has a ceiling value of $1,420.33 and a period of performance through January 31, 2025. This delivery order is part of a larger Indefinite...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the Department of Defense, to the prime contractor Amerisourcebergen Drug Corp. The contract is for the procurement of 4,566,756,418 units of Naloxone 2 mg/2 ml syringes, a critical medication used to treat opioid overdose. The contract has a ceiling value of $1,557.70 and a period of performance through December 19, 2024. It is a firm-fixed-price delivery order contract,...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of NALOXONE 10MG/0.4ML, a critical pharmaceutical product, with a ceiling value of $11,763.28 and a period of performance through October 2023. The contract represents a task order under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with...
  • SPE2D020D0014
    Indefinite Delivery Contract
  • SPE2D020D0014-SPE2D325F6844
    Delivery Order

This is a $59,220.00 firm fixed price delivery order contract awarded by the Defense Logistics Agency Troop Support Medical to Pfizer Inc., a large pharmaceutical manufacturer, for the supply of 4 mg/10 mL vials of Naloxone, an opioid overdose reversal medication. The contract has an ultimate completion date of February 27, 2025 and does not utilize any small business set-aside. Pfizer holds significant federal contract vehicles with the Department of Veterans Affairs, Centers for Disease Control and Prevention, and other government healthcare organizations, demonstrating its capabilities in supplying critical pharmaceutical products across diverse government programs.

Generated 6/1/25, 2:48 AM